Board of directors (16)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (16)
Company facts
- Chair
- Shailesh Jejurikar
- In S&P 500 since
- Mar 1957
- Incorporated in
- OH
- Fiscal year ends
- June
- SEC industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
- Craig ArnoldHONA · DirectorHON · DirectorKKR · DirectorMDT · Director
- Amy ChangCRM · DirectorDIS · Director
- M. Brett BiggsJBHT · DirectorYUM · Director
- Andre SchultenETN · Director
- Ashley McEvoyPODD · CEO
- Christine M. McCarthyCSGP · Director
- Christopher J. KempczinskiMCD · CEO
- Gary A. CoombeMAS · Director
- Jennifer L. DavisABBV · Director
- Jon R. MoellerLLY · Director
- Joseph JimenezGM · Director
- Ma Fatima FranciscoHPQ · Director
- Rajesh SubramaniamFDX · CEO
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Andre Schulten Chief Financial Officer | Sale | 33,624 | $165.00 | $5.5M |
| Nov 3, 2026 | Matthew W. Janzaruk SVP - Chief Accounting Officer | Sale | 9,479 | $163.00 | $1.5M |
| Oct 30, 2026 | Paul Gama CEO- Health Care | Sale | 2,894 | $165.00 | $478K |
| Oct 30, 2026 | Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer | Sale | 18,812 | $164.43 | $3.1M |
| Oct 30, 2026 | Sundar G. Raman CEO-Fabric Home & Habitat Care | Sale | 38,253 | $165.00 | $6.3M |
| Oct 23, 2026 | Shailesh Jejurikar Chairman, President and CEO | Sale | 35,000 | $163.09 | $5.7M |
| Oct 23, 2026 | Balaji Purushothaman Chief Human Resources Officer | Sale | 4,181 | $160.71 | $672K |
| Oct 23, 2026 | Paul Gama CEO- Health Care | Sale | 4,331 | $161.27 | $698K |
| Oct 5, 2026 | Andre Schulten Chief Financial Officer | Sale | 3,914 | $145.34 | $569K |
| Oct 5, 2026 | Paul Gama CEO- Health Care | Sale | 2,225 | $145.34 | $323K |
| Oct 5, 2026 | Susan Street Whaley Chief Legal Officer & Secy | Sale | 2,369 | $145.34 | $344K |
| Aug 24, 2026 | Matthew W. Janzaruk SVP - Chief Accounting Officer | Sale | 359 | $145.24 | $52K |
| Aug 21, 2026 | Sundar G. Raman CEO-Fabric Home & Habitat Care | Sale | 3,435 | $143.02 | $491K |
| Aug 20, 2026 | El Hak Hesham Abd CEO-Baby and Feminine Care | Sale | 1,936 | $143.79 | $278K |
| Aug 20, 2026 | De Azevedo Juliana Monteiro Santos CEO - Grooming | Sale | 2,368 | $143.79 | $340K |
| Aug 20, 2026 | Matthew W. Janzaruk SVP - Chief Accounting Officer | Sale | 156 | $143.79 | $22K |
| Aug 20, 2026 | Andre Schulten Chief Financial Officer | Sale | 5,402 | $143.79 | $777K |
| Aug 20, 2026 | Freddy P. Bharucha CEO - Beauty | Sale | 246 | $143.79 | $35K |
| Aug 20, 2026 | Balaji Purushothaman Chief Human Resources Officer | Sale | 2,019 | $143.79 | $290K |
| Aug 20, 2026 | Shailesh Jejurikar Chairman, President and CEO | Sale | 6,176 | $143.79 | $888K |
| Aug 20, 2026 | Paul Gama CEO- Health Care | Sale | 3,396 | $143.79 | $488K |
| Aug 20, 2026 | Susan Street Whaley Chief Legal Officer & Secy | Sale | 2,238 | $143.79 | $322K |
| Aug 20, 2026 | Marc S. Pritchard Chief Brand Officer | Sale | 4,030 | $143.79 | $579K |
| Aug 19, 2026 | Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer | Sale | 3,053 | $143.79 | $439K |
| Aug 18, 2026 | Susan Street Whaley Chief Legal Officer & Secy | Sale | 8,644 | $144.00 | $1.2M |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Jul 29, 2026
On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026. Mr. Moeller will remain with the Company through August 14, 2026, when he will retire from the Company. The Company also announced that Shailesh G. Jejurikar, currently President and Chief Executive Officer and a member of the Board, has been appointed Chairman of the Board, in addition to his current responsibilities, effective August 1, 2026, to serve at the pleasure of the Board. In addition, the non-employee Directors of the Board reappointed Joseph Jimenez as the Board’s independent Lead Director. The Company is filing the information under this item pursuant to
Read the 8-K filing - Dec 15, 2025
On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.
Read the 8-K filing - Oct 16, 2025
At the Annual Meeting of Shareholders of The Procter & Gamble Company (the "Company”), held on October 14, 2025, the Company’s shareholders approved The Procter & Gamble 2025 Stock and Incentive Compensation Plan (the “2025 Stock Plan”). The 2025 Stock Plan authorizes the award of up to 175,000,000 shares of the Company's common stock. Types of awards authorized under the 2025 Stock Plan include common stock, restricted stock units, performance stock units, stock options, and stock appreciation rights. In addition, the 2025 Stock Plan permits the award of any shares that remain available under The Procter & Gamble 2019 Stock and Incentive Compensation Plan, approved by shareholders on October 8, 2019. The Board of Directors approved the 2025 Stock Plan for submission to shareholders on August 12, 2025.
Read the 8-K filing - Aug 14, 2025
On August 12, 2025, Alexandra Keith, currently Chief Executive Officer – Beauty, announced her intention to retire from the Company effective February 20, 2026, after more than 36 years of service. At the time of her retirement, Ms. Keith will enter into the Company’s standard Written Separation Agreement, which will not provide any cash severance payment, but will allow her to retain the remainder of her special equity award scheduled to vest in August 2026. All other equity awards will be retained or pro-rated as described in the applicable Award Agreement.
Read the 8-K filing - Jul 28, 2025
On July 28, 2025, The Procter & Gamble Company (the "Company") announced the following executive changes: Jon Moeller, Chairman of the Board, President and Chief Executive Officer, will transition into the role of Executive Chairman of the Board, effective January 1, 2026, to serve at the pleasure of the Board of Directors. Shailesh Jejurikar (age 58), currently Chief Operating Officer, has been elected President and Chief Executive Officer, effective January 1, 2026, to serve at the pleasure of the Board of Directors. The Board has also nominated Mr. Jejurikar to stand for election to the Board at the Company’s annual shareholder meeting in October 2025, to be effective upon conclusion of the annual meeting. Mr. Jejurikar joined the Company in 1989 and has held positions of increasing responsibility since that time.
Read the 8-K filing - Jun 9, 2025
On June 9, 2025, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a Director of the Company, effective June 9. Mr. Arnold will serve on the Audit and Compensation & Leadership Development Committees. The Board has determined that Mr. Arnold is independent under the NYSE listing standards and the Company’s Independence Guidelines. Mr. Arnold will receive the same compensation as the other non-employee members of the Board of Directors, including a pro-rated annual RSU grant that reflects his June appointment date. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 23, 2024. The Company is filing the information under this item pursuant to
Read the 8-K filing - Apr 9, 2024
On April 9, 2024, Angela F. Braly notified The Procter & Gamble Company (the “Company”) of her decision to retire from the Company’s Board of Directors effective June 11, 2024. Ms. Braly made the decision in order to provide more time for her to focus on a range of activities and personal pursuits. The Company is filing the information under this item pursuant to
Read the 8-K filing - Dec 13, 2023
On December 12, 2023, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Ashley McEvoy, former Executive Vice President, Worldwide Chairman of MedTech at Johnson & Johnson, as a Director of the Company, effective December 12. Ms. McEvoy will serve on the Compensation & Leadership Development and Innovation & Technology Committees. The Board has determined that Ms. McEvoy is independent under the NYSE listing standards and the Company’s Independence Guidelines. Ms. McEvoy will receive the same compensation as the other non-employee members of the Board of Directors, including a pro-rated annual RSU grant that reflects her December appointment date. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 25, 2023. The Company is filing the information under this item pursuant to
Read the 8-K filing - Apr 11, 2023
On April 11, 2023, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Sheila Bonini, Senior Vice President – Private Sector Engagement for World Wildlife Fund, Inc., and Robert Portman, former United States Senator, as Directors of the Company, effective April 11, 2023. Ms. Bonini will serve on the Governance & Public Responsibility and Innovation & Technology Committees. Mr. Portman will serve on the Audit and Governance & Public Responsibility Committees. The Board has determined that Ms. Bonini and Mr. Portman are each independent under the NYSE listing standards and the Company’s Independence Guidelines. Ms. Bonini and Mr. Portman will each receive the same compensation as the other non-employee members of the Board of Directors. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 26, 2022.
Read the 8-K filing - Apr 14, 2022
On April 14, 2022, The Procter & Gamble Company (the "Company") announced that David S. Taylor, Executive Chairman of the Board, will retire from the Company, effective June 30, 2022. The Company also announced that Jon R. Moeller, currently President and Chief Executive Officer and a member of the Board of Directors (“the Board”), has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 1, 2022, to serve at the pleasure of the Board. In addition, the non-employee Directors of the Board reappointed Joseph Jimenez as the Board’s independent Lead Director. The Company is filing the information under this item pursuant to
Read the 8-K filing - Jan 12, 2022
On January 7, 2022, Michael G. Homan, currently Senior Vice President – Chief Accounting Officer, announced his intention to retire from The Procter & Gamble Company (the “Company”) after 24 years of service, effective July 31, 2022. Accordingly, on January 7, 2022, the Company’s Board of Directors designated Matthew W. Janzaruk (age 48), currently Vice President – Finance & Accounting, Global Internal Audit, as the Company’s principal accounting officer, effective March 1, 2022. Mr. Janzaruk has also been named Senior Vice President – Chief Accounting Officer, effective that same date. Mr. Janzaruk joined the Company in 2003 and has held positions of increasing responsibility since that time. He has served as Vice President – Finance & Accounting, Global Internal Audit since August 2016.
Read the 8-K filing - Dec 10, 2021
On December 8, 2021, President Joseph R. Biden, Jr., announced his intent to nominate Margaret C. Whitman, a Director of The Procter & Gamble Company (the “Company”), to serve as the United States Ambassador to Kenya. This nomination requires confirmation by the U.S. Senate. Ms. Whitman has notified the Company of her intent to resign from the Company’s Board of Directors, effective upon Senate confirmation of her appointment. The Company is filing this 8-K pursuant to
Read the 8-K filing - Aug 5, 2021
On August 4, 2021, Nelson Peltz notified The Procter & Gamble Company (the "Company") of his intention to conclude his service on the Company's Board of Directors at the end of his current term, which expires at the Company's upcoming annual meeting of shareholders, expected to be held on October 12, 2021. The Company is filing this 8-K pursuant to
Read the 8-K filing - Jul 29, 2021
On July 29, 2021, The Procter & Gamble Company (the "Company") announced the following executive changes: David S. Taylor, Chairman of the Board, President and Chief Executive Officer, will transition into the role of Executive Chairman of the Board, effective November 1, 2021, to serve at the pleasure of the Board of Directors. Jon R. Moeller (age 57), currently Vice Chairman and Chief Operating Officer, has been elected President and Chief Executive Officer, effective November 1, 2021, to serve at the pleasure of the Board of Directors. Mr. Moeller has also been appointed as a member of the Company’s Board of Directors, effective immediately. As an employee of the Company, Mr. Moeller will not serve on any Board committees.
Read the 8-K filing - Jun 11, 2021
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On June 8, 2021, the following executives of The Procter & Gamble Company (the "Company") announced their intention to retire: Mary Lynn Ferguson-McHugh, currently Chief Executive Officer – Family Care and New Business, announced her intention to retire from the Company effective October 1, 2021, after more than 35 years of service. Steven D. Bishop, currently Chief Executive Officer – Health Care, announced his intention to retire from the Company effective February 18, 2022, after more than 35 years of service. The Company is filing this 8-K pursuant to
Read the 8-K filing
Show 16 older changes
- Feb 10, 2021
On February 9, 2021, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed B. Marc Allen, chief strategy officer and senior vice president of Strategy and Corporate Development at The Boeing Company, as a Director of the Company, effective February 10, 2021. Mr. Allen will serve on the Audit and Innovation & Technology Committees. The Board has determined that Mr. Allen is independent under the NYSE listing standards and the Company’s Independence Guidelines. Mr. Allen will receive the same compensation as the other non-employee members of the Board of Directors. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 28, 2020. The Company is filing the information under this item pursuant to
Read the 8-K filing - Feb 9, 2021
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On February 9, 2021, the Board of Directors of The Procter & Gamble Company (the "Company") designated Michael (Mick) G. Homan (age 59), Senior Vice President—Corporate Accounting, as the Company’s principal accounting officer, effective March 1, 2021. Mr. Homan will assume the principal accounting officer designation currently held by Valarie L. Sheppard, Controller and Treasurer and Group Vice President – Company Transition Leader. Ms. Sheppard’s retirement, effective March 31, 2021, was previously announced. Mr. Homan has served as the Company’s Senior Vice President – Corporate Accounting since February 2006.
Read the 8-K filing - Dec 9, 2020
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On December 8, 2020, the Board of Directors of The Procter & Gamble Company (the "Company") elected Andre Schulten (age 50), currently Senior Vice President—Baby Care, North America, as the Company’s Chief Financial Officer, effective March 1, 2021, to serve at the pleasure of the Board of Directors. Jon Moeller, currently Vice Chairman, Chief Operating Officer and Chief Financial Officer, will remain Vice Chairman and Chief Operating Officer. Mr.
Read the 8-K filing - Sep 16, 2020
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On September 16, 2020, Valarie L. Sheppard, currently Controller and Treasurer and Group Vice President – Company Transition Leader and The Procter & Gamble Company’s principal accounting officer, announced her intention to retire from the Company after 35 years of service, effective March 31, 2021. The Company is filing this 8-K pursuant to
Read the 8-K filing - Aug 12, 2020
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On August 11, 2020, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Debra L. Lee, Chief Executive Officer of Leading Women Defined, Inc., and former Chairman and Chief Executive Officer of BET Networks, as a Director of the Company, effective August 12, 2020. Ms. Lee will serve on the Compensation & Leadership Development and Governance & Public Responsibility Committees. The Board has determined that Ms. Lee is independent under the NYSE listing standards and the Company’s Independence Guidelines. Ms. Lee will receive the same compensation as the other non-employee members of the Board of Directors. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 23, 2019.
Read the 8-K filing - Oct 11, 2019
At the Annual Meeting of Shareholders of The Procter & Gamble Company (“the Company”), held on October 8, 2019, the Company’s shareholders approved The Procter & Gamble 2019 Stock and Incentive Compensation Plan (the “2019 Stock Plan”). The 2019 Stock Plan authorizes the award of up to 150,000,000 shares of the Company's common stock. Types of awards authorized under the 2019 Stock Plan include common stock, restricted stock units, performance stock units, stock options, and stock appreciation rights. In addition, the 2019 Stock Plan permits the award of any shares that remain available under The Procter & Gamble 2014 Stock and Incentive Compensation Plan, approved by shareholders on October 14, 2014. The Board of Directors approved the 2019 Stock Plan for submission to shareholders on August 13, 2019.
Read the 8-K filing - Feb 13, 2019
Effective February 13, 2019, Dr. Ernesto Zedillo retired from the Board of Directors of The Procter & Gamble Company (the "Company") after 18 years of service, in accordance with the term limits set forth in the Company's Corporate Governance Guidelines. The Company is filing this 8-K pursuant to
Read the 8-K filing - Dec 27, 2018
On December 26, 2018, Kenneth I. Chenault notified The Procter & Gamble Company (the "Company") of his decision to retire from the Company's Board of Directors effective February 13, 2019. Mr. Chenault made this decision in order to allow more time to focus on a range of activities in the next phase of his life. The Company is filing this 8-K pursuant to
Read the 8-K filing - Jun 20, 2018
On June 19, 2018, Giovanni Ciserani, currently Group President–Global Fabric & Home Care and Global Baby & Feminine Care, notified The Procter & Gamble Company (the "Company") that he will retire from the Company effective November 30, 2018. The Company is filing this 8-K pursuant to
Read the 8-K filing - Jun 13, 2018
On June 12, 2018, the Compensation & Leadership Development Committee of the Board of Directors of The Procter & Gamble Company (the "Company") approved the amendment and restatement of the Summary of the Company's Short Term Achievement Reward Program ("STAR"), effective July 1, 2018. STAR is the Company's annual cash bonus program. Among other things, STAR was modified to expand the potential ranges for both the Company Factor and the Business Unit Factor to 0% - 200% from 70% - 130% and 50% - 150%, respectively; move from a multiplicative model for the Company Factor and the Business Unit Factor to an additive model for the two factors; and change from an equal weighting of the Company Factor and the Business Unit Factor in determining awards to a 30% / 70% weighting of the Company Factor and the Business Unit Factor, respectively.
Read the 8-K filing - Feb 16, 2018
(d) This Form 8-K/A is filed as an amendment to The Procter & Gamble Company's ("Company") Form 8-K filed on December 15, 2017 ("Original Filing"), that announced the appointment of Joseph Jimenez and Nelson Peltz to the Company's Board of Directors effective March 1, 2018. At the time of the Original Filing the Board had not determined committee assignments for Mr. Jimenez or Mr. Peltz. The Company is filing this Form 8-K/A to disclose that on February 13, 2018, the Board designated Mr. Jimenez as a member of the Compensation & Leadership Development and Innovation & Technology Committees and designated Mr. Peltz as a member of the Governance & Public Responsibility and Innovation & Technology Committees, in each case effective March 1, 2018.
Read the 8-K filing - Dec 15, 2017
(d) On December 15, 2017, the Board of Directors of The Procter & Gamble Company (the “Company”) increased the size of the Board from eleven to thirteen Directors and appointed Joseph Jimenez, Chief Executive Officer of Novartis AG, as a Director of the Company, effective March 1, 2018. The Board also appointed Nelson Peltz, Chief Executive Officer of Trian Fund Management, L.P., as a Director, effective March 1, 2018. The Company has agreed that Mr. Peltz will be included in the Company’s slate of nominees for election to the Board of Directors at the 2018 annual meeting of shareholders. Committee assignments for Mr. Jimenez and Mr. Peltz will be determined at a later date. Mr. Jimenez and Mr. Peltz will each receive the same compensation from the Company as the other non-employee members of the Board of Directors.
Read the 8-K filing - May 17, 2017
On May 15, 2017, Patrice Louvet, currently Group President-Global Beauty, notified The Procter & Gamble Company (the "Company") that he is resigning from the Company effective June 30, 2017. The Company is filing this 8-K pursuant to Items 5.02(b), "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."
Read the 8-K filing - Apr 12, 2017
(d) ELECTION OF DIRECTORS On April 11, 2017, the Board of Directors of The Procter & Gamble Company (the "Company") appointed Amy L. Chang, founder and Chief Executive Officer of Accompany, Inc., as a Director of the Company, effective June 1, 2017. Ms. Chang will serve on the Audit and Innovation & Technology Committees. The Company is filing this 8-K pursuant to
Read the 8-K filing - Aug 9, 2016
(b) DEPARTURE OF DIRECTORS On August 3, 2016, Dr. Susan Desmond-Hellmann notified The Procter & Gamble Company (the "Company") of her decision not to stand for re-election to the Company's Board of Directors at the October 11, 2016 annual shareholder meeting. Dr. Desmond-Hellmann made this decision in order to focus on her role as Chief Executive Officer of the Bill and Melinda Gates Foundation and Lead Independent Director of Facebook, Inc. In light of this decision and consistent with the terms of the Company's Code of Regulations, the Board has decreased the size of the Board from 11 to 10 members, effective with commencement of the Company's annual shareholder meeting. The Company is filing this 8-K pursuant to
Read the 8-K filing - Jun 1, 2016
On June 1, 2016, The Procter & Gamble Company (the "Company") announced that A.G. Lafley, Executive Chairman of the Board, will retire from the Company, effective June 30, 2016. The Company also announced that David Taylor, currently President and Chief Executive Officer and a member of the Board, has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 1, 2016, to serve at the pleasure of the Board of Directors (the "Board"). A copy of the Company's press release announcing these changes is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In conjunction with Mr. Lafley's retirement, the Board approved a resolution to reduce the size of the Board from 12 to 11 Directors. The non-employee Directors also voted to reappoint W. James McNerney, Jr. as the independent Lead Director for fiscal year 2016-17.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2026 | $87.0B | $16.0B | 18.4% | $6.62 | $126.5B |
| FY2025 | $84.3B | $16.0B | 19.0% | $6.51 | $125.2B |
| FY2024 | $84.0B | $14.9B | 17.7% | $6.02 | $122.4B |
| FY2023 | $82.0B | $14.7B | 17.9% | $5.90 | $120.8B |
| FY2022 | $80.2B | $14.7B | 18.4% | $5.81 | $117.2B |
| FY2021 | $76.1B | $14.3B | 18.8% | $5.50 | $119.3B |
| FY2020 | $71.0B | $13.0B | 18.4% | $4.96 | $120.7B |
| FY2019 | $67.7B | $3.9B | 5.8% | $1.43 | $115.1B |
Former directors and officers (33)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.